Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flairesse is a professional dental prophylaxis system developed by DMG Dental Material Gesellschaft mbH, designed for the prevention of dental caries and the treatment of tooth hypersensitivity. The product line includes various formulations such as varnishes, gels, foams, and prophylaxis pastes. The Flairesse varnish is a high-concentration fluoride delivery system containing 5% sodium fluoride (equivalent to 22,600 ppm of fluoride ions) and xylitol. Its mechanism of action is multifaceted: it promotes the remineralization of tooth enamel by facilitating the formation of fluorapatite, which is more resistant to acid-induced demineralization than the original hydroxyapatite. It also effectively seals exposed dentin tubules and hypersensitive areas at the tooth neck to provide rapid relief from sensitivity. The inclusion of xylitol helps to inhibit the growth of cariogenic bacteria and reduce acid production, further protecting the oral environment from decay.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flairesse.